{
    "id": "potassium_multipleChoice_v1",
    "type": "multipleChoice",
    "stem": "A patient with a potassium level of 3.1 mEq/L is prescribed an intravenous potassium chloride infusion. Which action by the nurse is essential for safe administration prior to starting the infusion?",
    "options": [
        {
            "id": "d",
            "text": "Dilute the potassium to a concentration of 100 mEq/L for peripheral use."
        },
        {
            "id": "a",
            "text": "Administer the infusion via IV push over 2 minutes."
        },
        {
            "id": "b",
            "text": "Verify a minimum urinary output of 30 mL/hr."
        },
        {
            "id": "c",
            "text": "Use a gravity drip to ensure rapid fluid replacement."
        }
    ],
    "correctOptionId": "b",
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Electrolytes",
            "Potassium",
            "IV Therapy"
        ]
    },
    "rationale": {
        "correct": "Potassium is primarily excreted by the kidneys. Before administering intravenous potassium, the nurse must ensure adequate renal function (minimum of 30 mL/hr urinary output). If the patient is oliguric or anuric, the administration of potassium can lead to rapid, life-threatening hyperkalemia. Verifying output is a critical safety step to prevent potassium toxicity and cardiac arrest.",
        "incorrect": "Intravenous potassium must NEVER be given as an IV push or bolus, as this causes immediate cardiac arrest. Gravity drips are unsafe for potassium due to the risk of accidental rapid infusion; an electronic infusion pump is mandatory. Concentrated potassium (e.g., 100 mEq/L) is extremely irritating to peripheral veins; the standard peripheral concentration limit is typically 40 mEq/L.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "\"Dilute the potassium to a concentration of 100 mEq/L for peripheral use.\" is a common distractor; it is either a non-specific finding or an action that follows more urgent stabilization.",
                "isCorrect": false
            },
            {
                "label": "B",
                "content": "Choosing \"Administer the infusion via IV push over 2 minutes.\" represents a misinterpretation of the gathered cues or a failure to prioritize physiological needs.",
                "isCorrect": false
            },
            {
                "label": "C",
                "content": "\"Verify a minimum urinary output of 30 mL/hr.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "D",
                "content": "In this specific NGN scenario, \"Use a gravity drip to ensure rapid fluid replacement.\" is incorrect as it introduces clinical risk or deviates from standard triage logic.",
                "isCorrect": false
            }
        ],
        "clinicalPearls": [
            "Potassium is a high-alert medication: Never Push, Always Pump, Always Dilute, and check those Kidneys!"
        ],
        "questionTrap": {
            "trap": "The 'Rapid Replacement' Distractor",
            "howToOvercome": "Always prioritize safety over speed when replacing electrolytes. Potassium must be infused slowly (usually no faster than 10 mEq/hr peripherally)."
        },
        "mnemonic": {
            "title": "K-K-K",
            "expansion": "K (Potassium) - K (Kidneys must work) - K (Kill if pushed)"
        },
        "reviewUnits": [
            {
                "heading": "Safe Electrolyte Administration",
                "body": "Intravenous potassium chloride (KCl) requires strict adherence to safety protocols including pre-administration renal assessment, use of infusion pumps, and appropriate dilution to prevent vein irritation and cardiac complications.",
                "source": "NCSBN 2026 Pharmacological Guidelines"
            }
        ]
    },
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    }
}